Systematic review / meta-analysis / 2020
Flaxseed supplementation significantly reduced total cholesterol, triglycerides, and LDL-C, but did not affect HDL-C in a meta-analysis of 62 RCTs.
A systematic review and dose-response meta-analysis of 62 RCTs with 3,772 participants examined the effects of flaxseed supplementation on blood lipid profiles. Flaxseed significantly reduced total cholesterol (WMD = -5.389 mg/dL; 95% CI: -9.483, -1.295, p = 0.010), triglycerides (WMD = -9.422 mg/dL; 95% CI: -15.514, -3.330, p = 0.002), and LDL-C (WMD = -4.206 mg/dl; 95% CI: -7.260, -1.151, p = 0.007). It had no significant effect on HDL-C (WMD = 0.047 mg/dl; 95% CI: -0.777, 0.872, p = 0.910). The authors noted that large-scale studies with better design are needed to confirm the results.
- Study type
- Systematic review and dose-response meta-analysis of RCTs
- Who was studied
- 3,772 participants across 62 RCTs
- What was measured
- Blood lipid profiles (total cholesterol, triglycerides, LDL-C, HDL-C)
THE PAPER
Effect of flaxseed supplementation on lipid profile: An updated systematic review and dose-response meta-analysis of sixty-two randomized controlled trials.
Hadi A, Askarpour M, Salamat S, Ghaedi E, Symonds ME, Miraghajani M. Pharmacol Res, 2020.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.